FDA Clearance Tracker · P990027-S015
TECHNOLAS PERFECT VISION 217Z ZYOPTIX SYSTEM FOR PERSONALIZED VISION CORRECTION
Last checked: Nov 20, 2026Latest source record: Nov 30, 2010 (this decision)Source: openFDAMethods & limitations
Decided
Nov 30, 2010
Approved
Time to decision
154 days
Received Jun 29, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990027-S015
- Device name
- TECHNOLAS PERFECT VISION 217Z ZYOPTIX SYSTEM FOR PERSONALIZED VISION CORRECTION
- Applicant
- Technolas Perfect Vision GmbH
- Applicant location
- MüNchen
- Received
- Jun 29, 2010
- Decided
- Nov 30, 2010
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P990027
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ADVANCED NOMOGRAM SOFTWARE MODULE AS AN UPGRADE TO THE EXISTING SOFTWARE OF THE TECHNOLAS PERFECT VISION® 217Z ZYOPTIX SYSTEM FOR PERSONALIZED VISION CORRECTION. THE ADVANCED NOMOGRAM RESIDES ON A SEPARATE COMPUTER WITH THE ZYLINK TREATMENTCALCULATION SOFTWARE, AND IT LEAVES ALL HARDWARE COMPONENTS AND THE LASER BEAM CONTROL SOFTWARE MODULE UNCHANGED. THE TECHNOLAS PERFECT VISION 217Z ZYOPTIX SYSTEM FOR PERSONALIZEDVISION CORRECTION WITH ADVANCED NOMOGRAM SOFTWARE MODULE IS INDICATED FOR WAVEFRONT-GUIDEDLASER ASSISTED IN-SITU KERATOMILEUSIS (LASIK):1) FOR THE REDUCTION OR ELIMINATION OF MYOPIA WITH SPHERE UP TO -7.00 D AND CYLINDER UP TO-3.00 D AND MRSE <=7.50 D AT THE SPECTACLE PLANE;2) IN PATIENTS WITH DOCUMENTED EVIDENCE OF A CHANGE IN MANIFEST REFRACTION OF LESS THAN OREQUAL TO +-0.50 DIOPTERS (IN BOTH CYLINDER AND SPHERE COMPONENTS) FOR AT LEAST ONE YEARPRIOR TO THE DATE OF THE PRE-OPERATIVE EXAMINATION; AND3) IN PATIENTS 21 YEARS OF AGE OR OLDER.
Source documents
Other decisions for Technolas Perfect Vision GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TECHNOLAS TENEO 317 (MODEL 2) Excimer Laser SystemPMA supplement
P990027-S021 · Decided Nov 22, 2023 · 293 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.